Literature DB >> 7509668

The fastest genome evolution ever described: HIV variation in situ.

S Wain-Hobson1.   

Abstract

Human immunodeficiency virus is an RNA virus in which the degree of genetic variation observed is phenomenal--up to 20% within an infected individual. This is essentially due to remorseless cycles of viral replication, most probably due to chronic activation of the immune system. It can be estimated that the number of variants in existence worldwide must be in excess of 10(14)-10(18), and given the nature of RNA viruses even more novel variants should emerge.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7509668     DOI: 10.1016/0959-437x(93)90008-d

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  27 in total

Review 1.  Viral mutation rates.

Authors:  Rafael Sanjuán; Miguel R Nebot; Nicola Chirico; Louis M Mansky; Robert Belshaw
Journal:  J Virol       Date:  2010-07-21       Impact factor: 5.103

2.  The potential for respiratory droplet-transmissible A/H5N1 influenza virus to evolve in a mammalian host.

Authors:  Colin A Russell; Judith M Fonville; André E X Brown; David F Burke; David L Smith; Sarah L James; Sander Herfst; Sander van Boheemen; Martin Linster; Eefje J Schrauwen; Leah Katzelnick; Ana Mosterín; Thijs Kuiken; Eileen Maher; Gabriele Neumann; Albert D M E Osterhaus; Yoshihiro Kawaoka; Ron A M Fouchier; Derek J Smith
Journal:  Science       Date:  2012-06-22       Impact factor: 47.728

Review 3.  Defective virus drives human immunodeficiency virus infection, persistence, and pathogenesis.

Authors:  Diana Finzi; Susan F Plaeger; Carl W Dieffenbach
Journal:  Clin Vaccine Immunol       Date:  2006-07

4.  Hyper-antigenic variation occurs with human rhinovirus type 17.

Authors:  L J Patterson; V V Hamparian
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

5.  Analysis of HIV-1 env gene sequences reveals evidence for a low effective number in the viral population.

Authors:  A J Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-04       Impact factor: 11.205

6.  Comparison of human immunodeficiency virus type 1 RNA sequence heterogeneity in cerebrospinal fluid and plasma.

Authors:  Y W Tang; J T Huong; R M Lloyd; P Spearman; D W Haas
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

7.  Associations between CYP2B6 polymorphisms and pharmacokinetics after a single dose of nevirapine or efavirenz in African americans.

Authors:  David W Haas; Tebeb Gebretsadik; Gail Mayo; Usha N Menon; Edward P Acosta; Ayumi Shintani; Michael Floyd; C Michael Stein; Grant R Wilkinson
Journal:  J Infect Dis       Date:  2009-03-15       Impact factor: 5.226

8.  Compartmentalization of human immunodeficiency virus type 1 between blood monocytes and CD4+ T cells during infection.

Authors:  Jennifer A Fulcher; Yon Hwangbo; Rafael Zioni; David Nickle; Xudong Lin; Laura Heath; James I Mullins; Lawrence Corey; Tuofu Zhu
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

9.  Self-association of the Lentivirus protein, Nef.

Authors:  Youn Tae Kwak; Alexa Raney; Lillian S Kuo; Sarah J Denial; Brenda R S Temple; J Victor Garcia; John L Foster
Journal:  Retrovirology       Date:  2010-09-23       Impact factor: 4.602

10.  Perinatal transmission of major, minor, and multiple maternal human immunodeficiency virus type 1 variants in utero and intrapartum.

Authors:  R E Dickover; E M Garratty; S Plaeger; Y J Bryson
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.